Journal of Peking University(Health Sciences) ›› 2018, Vol. 50 ›› Issue (5): 822-827. doi: 10.19723/j.issn.1671-167X.2018.05.010

• Article • Previous Articles     Next Articles

Perioperative parameters and prognosis analysis of patients aged 80 years or older treated with radical prostatectomy for prostate cancer

ZHANG Fan, ZHANG Shu-dong, XIAO Chun-lei, HUANG Yi△, MA Lu-lin   

  1. (Department of Urology, Peking University Third Hospital, Beijing, 100191)
  • Online:2018-10-18 Published:2018-10-18
  • Contact: HUANG Yi E-mail:pku_huang@163.com
  • Supported by:
    Supported by Beijing Municipal Science & Technology Commission (Z151100003915105)

Abstract: Objective: To assess the perioperative outcome, continence recovery and oncologic outcome of Chinese patients aged 80 years or older treated with radical prostatectomy for prostate cancer. Methods: We retrospectively evaluated the octogenarian patients who recieved biopsy for prostatic carcinoma and underwent laparoscopic radical prostatectomy from 2007 to 2016. We collected the data of clinical variables, perioperative parameters and postoperative pathological results for the octogenarian patients. We recorded and analyzed the recovery of urinary continence of the patients 3 months, 6 months and 1 year after surgery. Biochemical progression was defined as postoperative prostate specific antigen (PSA) greater than 2 μg/L for 2 times. We evaluated the non-biochemical recurrence survival rate and overall survival rate by Kaplan-Meier survival curve analysis for the patients aged 80 years or older. Multivariable COX regression analyses were used for evaluating the influence factors of biochemical recurrence after laparoscopic radical prostatectomy. Results: For all the 51 patients, the average age was (81.6±1.6) years,and prebiopsy PSA was (15.19±13.68) μg/L. There were 14 cases (27.5%), 19 cases (37.3%) and 18 cases (35.3%) for biopsy Gleason score 6, 7 and ≥8. There were 6 patients(11.8%) with clinical stage T1, 31 patients (60.8%) with clinical stage T2 and 14 patients (27.5%) with clinical stage T3.According to American Society of Anesthesiologists (ASA) classification, grade Ⅰ was in 6 patients and grade Ⅱ in 45 patients. All the octogenarian patients received extra-peritoneal laparoscopic radical prostatectomy. The average operation time was (189.6±69.1) min, the estimated blood volume was (169.9±163.5) mL, and 11 patients (21.6%) had perioperative complications. There were 29 cases (56.9%) and 22 cases (43.1%) staged for pT2 and pT3 based on postoperative pathological test. Of the pT3 patients, 18 (35.3%) and 4 (7.8%) were pT3a and pT3b.Eight cases (15.7%) presented Gleason score 6,21 cases (41.1%) 7 and 22 cases(43.1%) ≥8. Fourteen cases were positive surgical margin patients after surgery. Overall, the median follow up was 42 months. The continence rate of the octogenarian patients was 64.7%, 82.4% and 92.2% for 3 months, 6 months and 12 months after the surgery. Twelve cases (23.5%) had biochemical recurrence and 4 cases (7.8%) died in the follow up. There was 1 patient who died of prostate cancer progression and 3 died for other reasons. PSA (P=0.019), pT≥T3 (P=0.017) and positive surgical margin (P=0.020) were independent risk factors for biochemical recurrence of the octogenarian prostate cancer patients according to multivariable COX regression analysis. Conclusion: For well selected octogenarian prostate cancer patients, laparoscopic radical prostatectomy was a feasible treatment option. Octogenarian patients who received laparoscopic radical prostatectomy showed good oncologic outcome. PSA, pT≥T3 and positive surgical margin were independent risk factors for biochemical recurrence of octogenarian prostate cancer patients. 

Key words: Prostatic neoplasm, Prostatectomy, Octogenarians

CLC Number: 

  • R699.8
[1] ZHANG Fan,HUANG Xiao-juan,YANG Bin,YAN Ye,LIU Cheng,ZHANG Shu-dong,HUANG Yi,MA Lu-lin. Relationship between prostate apex depth and early recovery of urinary continence after laparoscopic radical prostatectomy [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 692-696.
[2] HAO Han,LIU Yue,CHEN Yu-ke,SI Long-mei,ZHANG Meng,FAN Yu,ZHANG Zhong-yuan,TANG Qi,ZHANG Lei,WU Shi-liang,SONG Yi,LIN Jian,ZHAO Zheng,SHEN Cheng,YU Wei,HAN Wen-ke. Evaluating continence recovery time after robot-assisted radical prostatectomy [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 697-703.
[3] Yi LIU,Zhi-jian LIU,Qi SHEN,Jing-yun WU,Yu FAN,De-run LI,Wei YU,Zhi-song HE. A clinical analysis of 14 cases of prostatic stromal tumor of uncertain malignant potential [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 621-624.
[4] Yi-chang HAO,Ye YAN,Fan ZHANG,Min QIU,Lang ZHOU,Ke LIU,Jian LU,Chun-lei XIAO,Yi HUANG,Cheng LIU,Lu-lin MA. Surgical strategy selection and experience summary of prostate cancer with positive single needle biopsy [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 625-631.
[5] Ye YAN,Hai-zhui XIA,Xu-sheng LI,Wei HE,Xue-hua ZHU,Zhi-ying ZHANG,Chun-lei XIAO,Yu-qing LIU,Hua HUANG,Liang-hua HE,Jian LU. Application of U-shaped convolutional neural network in auto segmentation and reconstruction of 3D prostate model in laparoscopic prostatectomy navigation [J]. Journal of Peking University(Health Sciences), 2019, 51(3): 596-601.
[6] ZHANG Fan, XIAO Chun-lei, ZHANG Shu-dong, HUANG Yi, MA Lu-lin. Relationship between recovery of urinary continence after laparoscopic radical prostatectomy and prostatic volume and intravesical prostatic protursion length [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 621-625.
[7] BI Yong-xiang, XIAO Min-hui, ZHANG Ning-nan, LI Xiao-yun, MAO Xiao-peng, ZHANG Ke, ZHANG Zhuo-rui, ZHAO Liang-yun. Construction and improvement of animal models with different positional osseous metastasis of prostate cancer in vivo [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 590-596.
[8] WANG Gong-wei, SHEN Dan-hua, ZHANG Wei-Yu, XU Ke-xin, XU Tao, HU Hao. Trends in Gleason scores of Chinese prostate carcinoma from 1995 to 2014 [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 801-805.
[9] LIU Zhuo, MA Lu-lin, ZHANG Shu-dong, LU Min, TIAN Yu, HE Qun, JIN Jie. Basal cell carcinoma of prostate: a report of three cases [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 720-724.
[10] ZUO Qiang, ZHANG Fan, HUANG Yi, MA Lu-lin, LU Min, LU Jian. Clinically predictive factors of Gleason score upgrading in patients after radical prostatectomy [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 603-606.
[11] HU Feng-zhan, YUAN Wan-qiong, WANG Xiao-lin, QIN Cai-peng, SHENG Zheng-zuo, DU Yi-qing, YIN Hua-qi, XU Tao. Knockdown of CMTM3 promotes migration and invasion of PC3 cell in vitro [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 594-597.
[12] ZHANG Feng-Bo, DU Yuan, SHAO Qiang, TIAN Ye. Treatment of local low/intermediate risk prostate cancer with low dose rate brachytherapy: a report of 133 cases at a single center [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 611-614.
[13] LIAO Xiao-Xing, XING Nian-Zeng, QIAO Peng, KANG Ning, ZHANG Jun-Hui, NIU Yi-Nong. "Sandwich” urethra reconstruction improves the early continence following laparoscopic radical prostatectomy [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 601-604.
[14] LIU Lei, HOU Xiao-Fei, MA Lu-Lin, ZHAO Lei, ZHANG Hong-Xian. Efficacy and outcome of palliative TURP in patients with bladder outlet obstruction induced by advanced prostate cancer [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 597-600.
[15] YANG Kai-Wei, YU Wei, SONG Yi, HUANG Li-Hua, HAN Wen-Ke, HE Zhi-Song, JIN Jie, ZHOU Li-Qun. Predictor analysis of PSA response of docetaxel combined with prednisone in the treatment of metastatic castration resistant prostate cancer [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 592-596.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 351 -354 .